March 10, 2014

A Maryland bill that is intended to help pharmacies in managing inventories and avoid potential drug shortages could create hardships for distributors, according to an FDA law blog.

March 10, 2014

Rite Aid introduced a new program, dubbed Rite Aid Health Alliance, which is a health management collaboration among various healthcare providers that provides comprehensive care and support to individuals with chronic and poly-chronic health conditions, and helps them achieve health improvement goals established by their physicians.

March 7, 2014

GN ReSound recently launched its ReSound LiNX in global markets as a hearing aid capable of streaming high-quality stereo sound from an iPhone, iPad and iPod touch without the need for an additional pendant-like device.

March 7, 2014

A study published online Friday shows that the omega-3 fatty acids EPA and DHA — commonly found in fatty fish and fish oil supplements — are as effective, if not more effective, in lowering blood pressure as some of the commonly recommended lifestyle changes like increasing physical activity and restricting alcohol and sodium intake.

March 7, 2014

Teva Pharmaceutical Industries will launch the generic version of Xeloda (capecitabine) tablets, 150 mg and 500 mg, in the United States.

March 7, 2014

A team of researchers from UCLA's Henry Samueli School of Engineering and Applied Science has developed a Google Glass application and a server platform that allow users of the wearable, glasses-like computer to perform instant, wireless diagnostic testing for a variety of diseases and health conditions.

March 6, 2014

In anticipation of the March 13 deadline for comments on the FDA's proposed rule on prescription generic drug labeling, 21 health industry groups submitted a new letter to the agency on Thursday, raising concerns about the proposed regulation.

March 6, 2014

Scientists from the Council for Responsible Nutrition addressed a key group of healthcare practitioners regarding recent studies on multivitamin and multimineral supplements in the Annals of Internal Medicine through a review published in the Natural Medicine Journal, the journal of the American Association of Naturopathic Physicians.

March 6, 2014

Grand View Research projects that the global mHealth market will reach well in excess of $20 billion from a base of $2 billion in 2012, as part of a recent market research study.

March 6, 2014

Lupin on Thursday announced that it received final approval from the Food and Drug Administration for both its doxycycline capsules and its ciprofloxacin for oral suspension.

March 6, 2014

McNeil Consumer Healthcare on Wednesday introduced a new form to the Zyrtec portfolio of allergy-relief products — an oral, dissolvable tablet.

March 6, 2014

CVS Caremark’s MinuteClinic and Robert Wood Johnson University Hospital have signed a clinical collaboration to enhance access to high-quality healthcare services at MinuteClinic in New Jersey's Middlesex and Mercer counties.

March 6, 2014

Could retail-based health clinics be coming soon to Boston? While it appears that there are no definite plans in the works, a spokeswoman for Mayor Martin J. Walsh reportedly said that he has no intention of blocking the clinics from coming to Boston, the Boston Herald reported.

March 6, 2014

The administration is seeking $4.7 billion for the Food and Drug Administration, representing a 6.8% increase, according to a report published Tuesday by the Washington Post.

March 6, 2014

Study results announced Thursday by Novo Nordisk and collaborative partners found that participation in diabetes education is associated with a greater sense of well-being and the ability to self-manage diabetes.

March 5, 2014

Most people who abuse prescription opioid drugs get them for free from a friend or relative — but those at highest risk of overdose are as likely to get them from a doctor’s prescription, Centers for Disease Control researchers reported Monday in a research letter, “Sources of Prescription Opioid Pain Relievers by Frequency of Past-Year Nonmedical Use: United States, 2008-2011,” in the Journal of the American Medical Association Internal Medicine.

March 5, 2014

Dr. Reddy's Labs announced the launch of moxifloxacin hydrochloride tablets — the generic version of Avelox tablets — in 400-mg form.

March 5, 2014

Upsher-Smith Labs introduced a new educational program created for patients living with seizure clusters, as well as their families and friends.

March 4, 2014

Eden Sulzer, director of Cardinal Health’s Women in Pharmacy initiative, on Tuesday will discuss the unprecedented opportunity female pharmacists have to assume community pharmacy ownership roles during a panel discussion at the 2014 International Women's Day Forum, taking place at the United Nations.

March 4, 2014

Teva Pharmaceutical Industries announced that it received approval for generic Evista (raloxifene) tablets, 60-mg, in the United States.

March 3, 2014

AstraZeneca received approval from the Food and Drug Administration for its Bydureon pen (exenatide extended-release for injectable suspension) 2-mg, which is to be used as an addition to diet and exercise to improve glycemic control in adults with Type 2 diabetes.

March 3, 2014

Cardinal Health Specialty Solutions on Monday announced the acquisition of privately held Sonexus Health, a Dallas-based company that offers a range of patient access and specialty commercialization services.

March 3, 2014

Last week, more than 30 organizations — including the American Medical Association, Infectious Diseases Society of America and Pew Charitable Trusts — urged Congressional leaders to strengthen the labeling requirements for drugs approved under the proposed Antibiotic Development to Advance Patient Treatment Act of 2013 (ADAPT Act) limited population approval pathway, which will streamline regulatory approval for antibiotics.

March 3, 2014

An international team led by researchers at the Broad Institute and Massachusetts General Hospital has identified mutations in a gene that can reduce the risk of developing Type 2 diabetes, even in people who have such risk factors as obesity and old age, the group announced Sunday.